Clinical trial
HYPO2-BOOST GBM Trial: Hypoxia-targeted Radiotherapy Boost for GBM
NCT07769918 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HYPO2-BOOST GBM Trial: Hypoxia-targeted Radiotherapy Boost for GBM
- Lead sponsor
- NYU Langone Health
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 1, 2026
- Completion date
- June 1, 2029
- Enrollment
- 25 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
glioblastoma (gbm)